National Bank Of Canada Cybin Inc. Transaction History

National Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.38 - $0.65 $608 - $1,040	-1,600 Reduced 25.96%	4,563 $1,000
Q4 2022 Jan 24, 2023	SELL	$0.26 - $0.64 $2,600 - $6,400	-10,000 Reduced 61.87%	6,163 $0
Q3 2022 Oct 13, 2022	BUY	$0.48 - $1.11 $768 - $1,776	1,600 Added 10.99%	16,163 $9,000
Q1 2022 May 05, 2022	BUY	$0.74 - $1.22 $6,558 - $10,812	8,863 Added 155.49%	14,563 $11,000
Q4 2021 Jan 24, 2022	BUY	$1.13 - $2.31 $6,440 - $13,167	5,700 New	5,700 $7,000

185K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $2.07B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.